Palmidrol/Pregabalin
帕米醇/普瑞巴林
Report date: 2022/01/14 13:23:58
Base Information
Drug NamePalmidrol/Pregabalin
Drug Alias Name +[11]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes PalmidrolPregabalin
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPrismic Pharmaceuticals
China Registration ClassN/A
Develop Information
Active CompaniesPrismic Pharmaceuticals
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A